2 unchanged sentences
On July 30, 2019, our Board of Directors approved an increase in the May 7, 2019 authorization of an additional amount of $300.0 million (net of taxes, fees and commissions).
−Removed: As of June 30, 2022, there was approximately $294.6 million (net of taxes, fees and commissions) of remaining availability under a Board authorized share repurchase program.
+Added: As of September 30, 2022, there was approximately $249.4 million (net of taxes, fees and commissions) of remaining availability under the Board authorized share repurchase program.
The share repurchase program has no specified expiration date.
3 unchanged sentences
The suspension was lifted effective February 10, 2022, enabling the Company to resume stock repurchases pursuant to the prior authorizations .
−Removed: During the first three months of fiscal 2023, we repurchased 68,177 of our ordinary shares for the aggregate amount of $14.3 million (net of fees and commissions) pursuant to the authorizations.
−Removed: During the first three months of fiscal 2023, we obtained 57,704 of our ordinary shares in the aggregate amount of $11.7 million in connection with share based compensation award programs.
−Removed: The following table summarizes the ordinary shares repurchase activity during the first quarter of fiscal 2023 under our ordinary share repurchase program:
+Added: During the first six months of fiscal 2023, we obtained 64,436 of our ordinary shares in the aggregate amount of $11.8 million in connection with share based compensation award programs.
+Added: The following table summarizes the ordinary shares repurchase activity during the second quarter of fiscal 2023 under our ordinary share repurchase program:
Total Number of
8 unchanged sentences
Plans at Period End (in thousands)
−Removed: April 1-30 — $ — — (1) $ 308,932 (1)
−Removed: May 1-31 — — — 308,932
−Removed: June 1-30 68,177 209.50 68,177 294,649
+Added: July 1-31 63,865 $ 212.79 63,865 $ 281,059
+Added: August 1-31 68,838 209.93 68,838 265,109
+Added: September 1-30 91,607 188.16 91,607 $ 249,371
Total 224,310 (1) 201.85 (1) 224,310 249,371
−Removed: (1) See narrative above for details regarding the share repurchase program.
(1) Does not include 14 shares purchased during the quarter at an average price of $205.83 per share by the STERIS Corporation 401(k) Plan on behalf of an executive officer of the Company who may be deemed to be an affiliated purchaser.
+Added: Exhibits required by Item 601 of Regulation S-K
+Added: Exhibit Description
+Added: 3.1 STERIS plc Amended Memorandum and Articles of Association (filed as Exhibit 3.1 to STERIS plc Form 10-K for the fiscal year ended March 31, 2019 (Commission File No.
+Added: 001-38848), and incorporated herein by reference.
+Added: 10.1 Form of Deed of Indemnity for STERIS plc Directors and executive officers (Ireland and United Kingdom) (filed as Exhibit 10.1 to the STERIS plc Form 10-Q for the quarterly period ended June 30, 2022 (Commission File No.
+Added: 001-38848) and incorporated herein by reference)*
+Added: 10.2 Form of Deed of Indemnity for STERIS plc Directors and executive officers (Ireland)* (filed as Exhibit 10.2 to the STERIS plc Form 10-Q for the quarterly period ended June 30, 2022 (Commission File No.
+Added: 001-38848) and incorporated herein by reference)*
+Added: 10.3 Form of Indemnification Agreement between STERIS Corporation and certain director and executive officers of STERIS plc (filed as Exhibit 10.3 to the STERIS plc Form 10-Q for the quarterly period ended June 30, 2022 (Commission File No.
+Added: 001-38848) and incorporated herein by reference)*
+Added: 10.4 Description of STERIS Non-Employee Director Compensation Program*
+Added: 15.1 Letter Re:
+Added: Unaudited Interim Financial Information.
+Added: 22.1 List of Guarantor Subsidiaries with respect to the 2.700% Notes due 2031 and 3.750% Notes due 2051 issued by STERIS Irish Finco Unlimited Company (filed as Exhibit 22.1 to Form 10-K for the fiscal year ended March 31, 2021 (Commission File No.
+Added: 001-38848), and incorporated by reference).
+Added: 31.1 Certification of the Principal Executive Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a).
+Added: 31.2 Certification of the Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a).
+Added: 32.1 Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
+Added: 101.SCH Inline Schema Document.
+Added: 101.CAL Inline Calculation Linkbase Document.
+Added: 101.DEF Inline Definition Linkbase Document.
+Added: 101.LAB Inline Labels Linkbase Document.
+Added: 101.PRE Inline Presentation Linkbase Document.
+Added: 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: *A management contract or compensatory plan or arrangement required to be filed as an exhibit hereto
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Vice President, Controller and Chief Accounting Officer
+Added: November 9, 2022
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.